Cargando…
Presence of a 34-gene signature is a favorable prognostic marker in squamous non-small cell lung carcinoma
BACKGROUND: The tumor immune microenvironment is a heterogeneous entity. Gene expression analysis allows us to perform comprehensive immunoprofiling and may assist in dissecting the different components of the immune infiltrate. As gene expression analysis also provides information regarding tumor c...
Autores principales: | Theelen, W. S. M. E., Krijgsman, O., Monkhorst, K., Kuilman, T., Peters, D. D. G. C., Cornelissen, S., Ligtenberg, M. A., Willems, S. M., Blaauwgeers, J. L. G., van Noesel, C. J. M., Peeper, D. S., van den Heuvel, M. M., Schulze, K. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7333331/ https://www.ncbi.nlm.nih.gov/pubmed/32620126 http://dx.doi.org/10.1186/s12967-020-02436-3 |
Ejemplares similares
-
Absence of PD-L1 expression on tumor cells in the context of an activated immune infiltrate may indicate impaired IFNγ signaling in non-small cell lung cancer
por: Theelen, Willemijn S. M. E., et al.
Publicado: (2019) -
FGFR1, 2 and 3 protein overexpression and molecular aberrations of FGFR3 in early stage non‐small cell lung cancer
por: Theelen, Willemijn SME, et al.
Publicado: (2016) -
Phenotypic diversity drives paracrine drug tolerance
por: Kuilman, Thomas, et al.
Publicado: (2017) -
Neoadjuvant tamoxifen synchronizes ERα binding and gene expression profiles related to outcome and proliferation
por: Severson, Tesa M., et al.
Publicado: (2016) -
SERPINB9 is commonly amplified and high expression in cancer cells correlates with poor immune checkpoint blockade response
por: Ibáñez-Molero, Sofía, et al.
Publicado: (2022)